Iqbal J Hussain Centessa Pharmaceuticals PLC (CNTA) insider trading activity

Iqbal J Hussain is General Counsel of Centessa Pharmaceuticals plc. Currently has a direct ownership of 118,265 shares of CNTA, which is worth approximately $1.95 Million. The most recent transaction as insider was on Jan 15, 2025, when has been sold 6,000 shares (Ordinary Shares) at a price of $15.29 per share, resulting in proceeds of $91,740. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K

40.12% 3M change

36.22% 12M change

Total Value Held $1.95 Million

IQBAL J HUSSAIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 15 2025	SELL Open market or private sale	$91,740 $15.29 p/Share	6,000 Reduced 4.83%	118,265 Ordinary Shares
Jan 15 2025	BUY Exercise of conversion of derivative security	$35,040 $5.84 p/Share	6,000 Added 4.61%	124,265 Ordinary Shares
Dec 31 2024	SELL Payment of exercise price or tax liability	$122,952 $16.35 p/Share	7,520 Reduced 5.98%	118,265 Ordinary Shares
Dec 16 2024	SELL Open market or private sale	$1,273,584 $16.39 p/Share	77,705 Reduced 38.19%	125,785 Ordinary Shares
Dec 16 2024	BUY Exercise of conversion of derivative security	$35,040 $5.84 p/Share	6,000 Added 2.86%	203,490 Ordinary Shares
Sep 30 2024	SELL Payment of exercise price or tax liability	$118,740 $15.79 p/Share	7,520 Reduced 3.67%	197,490 Ordinary Shares
Jun 30 2024	SELL Payment of exercise price or tax liability	$67,905 $9.03 p/Share	7,520 Reduced 3.54%	205,010 Ordinary Shares
Mar 31 2024	SELL Payment of exercise price or tax liability	$84,976 $11.3 p/Share	7,520 Reduced 3.42%	212,530 Ordinary Shares
Feb 01 2024	SELL Payment of exercise price or tax liability	$64,578 $8.19 p/Share	7,885 Reduced 3.46%	220,050 Ordinary Shares
Feb 01 2024	BUY Grant, award, or other acquisition	-	42,500 Added 15.72%	227,935 Ordinary Shares
Dec 31 2023	SELL Payment of exercise price or tax liability	$59,859 $7.96 p/Share	7,520 Reduced 3.9%	185,435 Ordinary Shares
Sep 30 2023	SELL Payment of exercise price or tax liability	$48,654 $6.47 p/Share	7,520 Reduced 3.75%	192,955 Ordinary Shares
Jun 30 2023	SELL Payment of exercise price or tax liability	$41,913 $5.9 p/Share	7,104 Reduced 3.42%	200,475 Ordinary Shares
Mar 31 2023	SELL Payment of exercise price or tax liability	$27,612 $3.9 p/Share	7,080 Reduced 3.3%	207,579 Ordinary Shares
Feb 01 2023	BUY Grant, award, or other acquisition	-	67,100 Added 23.81%	214,659 Ordinary Shares
Dec 31 2022	SELL Payment of exercise price or tax liability	$12,387 $3.1 p/Share	3,996 Reduced 2.45%	159,004 Ordinary Shares
Oct 03 2022	SELL Open market or private sale	$18,024 $3.95 p/Share	4,563 Reduced 2.86%	154,712 Ordinary Shares
Sep 30 2022	SELL Payment of exercise price or tax liability	$48,641 $4.25 p/Share	11,445 Reduced 7.02%	151,555 Ordinary Shares
Sep 30 2022	SELL Open market or private sale	$15,161 $4.07 p/Share	3,725 Reduced 2.29%	159,275 Ordinary Shares
Jul 01 2022	BUY Grant, award, or other acquisition	-	160,000 Added 49.54%	163,000 Ordinary Shares
Jun 02 2021	BUY Open market or private purchase	$60,000 $20.0 p/Share	3,000 Added 50.0%	3,000 Ordinary Shares

IJH

Iqbal J Hussain

General Counsel

Cheshire, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Value

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA

Account